Tizanidine Tablet
Product Images NDC 43063-455

This is a medication called Tizanidine. It is available in tablet form with each tablet containing 4 mg of Tizanidine Hydrochloride USP equivalent to 4 mg Tizanidine base. This medicine can cause drowsiness, and therefore, one should be cautious while driving or performing tasks requiring mental alertness. Tizanidine tablets and capsules are not interchangeable. It should be kept out of the reach of children. The dosage and storage instructions are provided in the package insert. The package also contains the lot number, expiration date, and reorder number. In case of side effects, patients should call their doctor and can report them to FDA at 1-800-FDA-1088. The tablet should be taken multiple times a day. No information is available about the text at the bottom of the scan.*

The text describes a table showing plasma Tzanidine concentration in ng/mL at certain time intervals after patients took different doses of Tzanidine tablets or capsules with or without food. The table has four columns indicating different dosages and food intake instructions and six rows indicating the time intervals from dosing. There is also some unreadable text at the end.*

The text describes the improvement in Ashworth score caused by Zanidine with a mean dose of 28.6mg. The study was conducted for 7 weeks, and the results were observed from the 3rd week up to the endpoint. Therefore, the text provides evidence of the effectiveness of Zanidine in reducing Ashworth score in the given period.*